Skip to nav Skip to content

Clinical Trial Search

366 Clinical Trials Found

Clinical Trial 22177

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (cilta-cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma
Disease Site: Multiple Myeloma
PI: Alsina, Melissa

Clinical Trial 24006

Disease Site: Other
PI: Mason, Tina

Clinical Trial 22140

Working through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDERS)
Disease Site: Unknown Sites
PI: Vadaparampil, Susan

Clinical Trial 23433

Disease Site: Breast
PI: Ahmed, Kamran

Clinical Trial 20737

Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel That is Nonconforming for Commercial Release
Disease Site: Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's Lymphoma
PI: Locke, Frederick

Clinical Trial 22140-AIM2

Disease Site: Unknown Sites
PI: Vadaparampil, Susan

Clinical Trial 19646

Prospective Observational Cohort Study of Patients with Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Disease Site: Breast
PI: Extermann, Martine

Clinical Trial 23558

Disease Site: Leukemia, other, Lymphoid Leukemia
PI: Tinsley Vance, Sara

Clinical Trial 23803

Disease Site: Lip, Oral Cavity and Pharynx
PI: Vinci, Christine

Clinical Trial 23513

Assessing the DCIS Test Effect on Treatment Strategies in Patients with Ductal Carcinoma in Situ After Breast-Conserving Surgery
Disease Site: Breast
PI: Diaz, Roberto

Clinical Trial 22098

Non-Invasive Biomarkers in Prostate Cancer Disease Management
Disease Site: Prostate
PI: Balagurunathan, Yoganand (Yoga)

Clinical Trial 20788

An Advanced MRI Abdomen Protocol to Evaluate Pancreatic Ductal Adenocarcinoma in Surgically Resectable and Borderline Resectable Disease for Loco-Regional Heterogeneity and To Evaluate Treatment Response Status Post Surgery and MRI-GRT
Disease Site: Pancreas
PI: Costello, James